Market Size, Forecast, and Trend Highlights Over 2025-2034
U.S. Lidocaine Patches Market size was valued at USD 560.7 million in 2024 and is projected to reach a valuation of USD 963 million by the end of 2034, rising at a CAGR of 5.5% during the forecast period, i.e., 2025-2034. In 2025, the industry size of U.S. lidocaine patches is assessed at USD 591.2 million.
The U.S. lidocaine patches market is witnessing expansion due to an aging population and a growing demand for non-opioid pain management solutions. This aging population is indicative of the growing demand for targeted pain therapies like lidocaine patches. For instance, in February 2024, Scilex Holding Company announced that its flagship product, ZTlido, has more than one million users. Such advancements reinforce the growing adoption of lidocaine patches for safe, localized pain relief. Government healthcare initiatives on palliative care and pain management also further drive market growth.
The United States lidocaine patches market is evolving with innovative product developments that are offering superior pain relief options to the consumer. Hisamitsu America introduced the Salonpas Pain Relieving FLEX Patch Lidocaine 4% in June 2022, characterized by superior flexibility for improved wearability. These developments are a response to the increasing burden of chronic diseases, including arthritis and cancer, for which palliative care solutions are imperative. Moreover, government-supported programs aimed at substituting opioids with other painkillers reflect a general approach to the problem of opioid addiction and, thus, accelerate the demand for lidocaine patches in the U.S.
